Results of AGM

RNS Number : 8100C

IXICO plc

20 March 2014

 



20 March 2014

Results of AGM

IXICO plc (Ticker: IXI) ("IXICO" or the "Company"), the brain health company, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.

About IXICO

IXICO, the brain health company, was founded in 2004 with a mission to translate image acquisition, management and analysis technology and know-how, which the founders had developed together, into commercial products targeting the expanding area of imaging to inform decision-making during drug development. This has resulted in commercially successful products being launched in the clinical trials (Phase 0-III) and experimental medicine markets and more recently launched into the wider clinical diagnostic market. Since incorporation, IXICO has been awarded contracts by nine of the top 15 global pharmaceutical companies as well as leading biotechnology companies. In October 2013, IXICO plc was admitted to trading on AIM. More information is available on www.ixico.com

Enquiries:

IXICO plc 

Derek Hill, CEO

Charles Spicer, VP Corporate Development

[phone]

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel

Clare Terlouw

[phone]

Daniel Stewart & Company (Joint Broker)

Mark Treharne

David Hart

[phone]

FTI Consulting Limited (Investor Relations)

Ben Atwell

Simon Conway

John Dineen

[phone]

 

END

 

 

RAGSESFESFLSELD